{"id":"W2903023839","doi":"10.1016/j.euo.2018.11.006","title":"Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials","year":2018,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Cabozantinib; Docetaxel; Prostate cancer; Oncology; Abiraterone acetate; Internal medicine; Enzalutamide; Hazard ratio; Mitoxantrone; Prednisone; Cancer; Urology; Confidence interval; Chemotherapy; Androgen receptor; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002731934,0.0002535029,0.001618777,0.0005761767,0.0001811773,0.00001651946,0.0001682072,0.00006649343,0.0004172929],"category_scores_gemma":[0.0007861424,0.0001845603,0.0005332331,0.0008070131,0.0006066664,0.00006800263,0.00006339322,0.0001902349,0.00002027544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001067617,"about_ca_system_score_gemma":0.000695898,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006344024,"about_ca_topic_score_gemma":0.0001812139,"domain_scores_codex":[0.9961818,0.001458182,0.001024944,0.000533112,0.0002340324,0.0005679098],"domain_scores_gemma":[0.9974402,0.0007817524,0.0006838751,0.0003553111,0.0005480506,0.0001908509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1998396,0.01268244,0.03930858,0.0007057242,0.1156586,0.009585946,0.01514916,0.0002540456,0.4610298,0.004152096,0.01307673,0.1285572],"study_design_scores_gemma":[0.4291469,0.1616031,0.04785963,0.0002524474,0.1395846,0.0002083939,0.001653273,0.01136437,0.06912811,0.001032708,0.1365177,0.001648754],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877755,0.002179964,0.0004596458,0.002589737,0.0005446114,0.002809643,0.0003989523,0.00006659028,0.003175363],"genre_scores_gemma":[0.9950675,0.00008057761,0.002107401,0.0005519945,0.0002796631,0.0003358762,0.0004142428,0.00005002703,0.001112692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3919017,"threshold_uncertainty_score":0.752615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1105046009274817,"score_gpt":0.4826046893328425,"score_spread":0.3721000884053608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}